|
Resolution: standard / high Figure 3.
Weights for MCDA Value Matrix components and scores for growth hormone for Turner
syndrome in Canada (average data from eight panelists). *A five point weighting scale was used with 1 lowest and 5 highest weight. **A short
four point scoring scale was used with 0 lowest (to account for component that would
not bring any value) and 3 highest score.
Goetghebeur et al. Cost Effectiveness and Resource Allocation 2010 8:4 doi:10.1186/1478-7547-8-4 |